Fast Facts
-
Significant Bitcoin Losses: Semler Scientific reported unrealized losses of approximately $41.8 million on its Bitcoin holdings due to price drops from $93,500 to nearly $82,000 between January and March 2025.
-
Continued Investment in Bitcoin: Despite the losses, the company holds 3,182 BTC, maintaining its position as the twelfth-largest corporate Bitcoin holder, and plans to continue accumulating Bitcoin.
-
Financial Outlook and Securities Issuance: Projecting quarterly revenues between $8.8 million and $8.9 million amid operating losses of $1.3 to $1.5 million, Semler plans to issue up to $500 million in securities for corporate purposes, including further cryptocurrency purchases.
- Legal Settlement with DOJ: Semler reached an agreement-in-principle with the Department of Justice to potentially pay around $30 million to resolve allegations of False Claims Act violations, although a finalized agreement is not yet guaranteed.
Semler Scientific Reports $41.8 Million Bitcoin-Related Paper Loss in Q1 2025
Medial diagnostics company Semler Scientific announced a paper loss of approximately $41.8 million related to its Bitcoin holdings in its recent SEC filing, dated April 15. This substantial loss reflects the sharp decline in Bitcoin prices, which fell from $93,500 in January to nearly $82,000 by the end of March.
Despite this downturn, Semler maintains a significant investment in Bitcoin, holding 3,182 BTC as of March 31. The firm ranks as the twelfth-largest corporate Bitcoin holder globally, just ahead of Boyaa Interactive International Limited. CEO Doug Murphy-Chutorian emphasized the company’s commitment to both Bitcoin accumulation and ongoing innovation in healthcare.
Financially, Semler projects quarterly revenue between $8.8 million and $8.9 million, though it anticipates operating losses of $1.3 million to $1.5 million. As of the end of March, the company reported around $10 million in cash and cash equivalents.
In a bold move, Semler plans to issue up to $500 million in securities to fund its general corporate activities, including further cryptocurrency purchases. However, investor sentiment remains cautious, as the company’s stock—traded under the ticker SMLR on Nasdaq—has dropped by over 22% since the beginning of the year.
In a separate update, Semler reached an agreement in principle with the Department of Justice to settle legal issues dating back to 2017. The firm is prepared to pay about $30 million to resolve allegations of violating the False Claims Act related to improper marketing practices tied to Medicare billing. While this settlement marks progress, Semler noted that a finalized agreement is not yet confirmed.
Semler Scientific’s mixed financial outlook highlights the intersection of cryptocurrency and healthcare technology. As the company navigates these challenges, its approach could influence broader trends in corporate investments in digital assets.
Discover More Technology Insights
Dive deeper into the world of Cryptocurrency and its impact on global finance.
Explore past and present digital transformations on the Internet Archive.
Disclaimer
This content is for informational and entertainment purposes only and does not constitute financial or investment advice. Cryptocurrency is highly speculative and carries significant risk, including the potential loss of your entire investment. Do not make financial decisions based on this information. Consult a licensed financial advisor before investing. This site does not offer, sell, or advise on cryptocurrency, securities or other regulated financial products in compliance with SEC and applicable laws. Please do your own research and seek professional advise.
CryptoV1
